Spinal muscular atrophy adult - nusinersen or risdiplam - initial authority application form (PB334)

Use this form to apply for initial PBS-subsidised treatment with nusinersen or risdiplam for patients aged 19 years or over with spinal muscular atrophy.

Page last updated: 1 November 2024.
QC 62999